Combined De-Novo Mutation and Non-Random X-Chromosome Inactivation Causing Wiskott-Aldrich Syndrome in a Female with Thrombocytopenia

2013 ◽  
Vol 33 (7) ◽  
pp. 1150-1155 ◽  
Author(s):  
Boonchai Boonyawat ◽  
Santhosh Dhanraj ◽  
Fahad al Abbas ◽  
Bozana Zlateska ◽  
Eyal Grunenbaum ◽  
...  
2021 ◽  
Vol 56 (9) ◽  
pp. 1234-1235
Author(s):  
Guifeng Wei ◽  
Mafalda Almeida ◽  
Joseph S. Bowness ◽  
Tatyana B. Nesterova ◽  
Neil Brockdorff

Changing DNA methylation patterns during embryonic development are discussed in relation to differential gene expression, changes in X-chromosome activity and genomic imprinting. Sperm DNA is more methylated than oocyte DNA, both overall and for specific sequences. The methylation difference between the gametes could be one of the mechanisms (along with chromatin structure) regulating initial differences in expression of parental alleles in early development. There is a loss of methylation during development from the morula to the blastocyst and a marked decrease in methylase activity. De novo methylation becomes apparent around the time of implantation and occurs to a lesser extent in extra-embryonic tissue DNA. In embryonic DNA, de novo methylation begins at the time of random X-chromosome inactivation but it continues to occur after X-chromosome inactivation and may be a mechanism that irreversibly fixes specific patterns of gene expression and X-chromosome inactivity in the female. The germ line is probably delineated before extensive de novo methylation and hence escapes this process. The marked undermethylation of the germ line DNA may be a prerequisite for X-chromosome reactivation. The process underlying reactivation and removal of parent-specific patterns of gene expression may be changes in chromatin configuration associated with meiosis and a general reprogramming of the germ line to developmental totipotency.


2021 ◽  
Vol 9 ◽  
Author(s):  
Xuening Hou ◽  
Jie Sun ◽  
Chen Liu ◽  
Jihong Hao

Wiskott-Aldrich syndrome (WAS) is a rare X-linked immunodeficiency disorder caused by abnormal expression of Wiskott-Aldrich syndrome protein due to WAS gene mutation, which is generally characterized by microthrombocytopenia, eczema, recurrent infections, and high risk of autoimmune complications and hematological malignancies. Although affected males with WAS usually manifest severe symptoms, female carriers have no significant clinical manifestations. Here, we describe a Chinese girl diagnosed with WAS carrying a heterozygous missense mutation in exon 2 of the WAS gene. The patient presented with persistent thrombocytopenia with small platelets and decreased WAS protein detected by flow cytometry and western blot analysis. The methylation analysis of the HUMARA gene displayed an extremely skewed X-chromosome inactivation (SXCI) pattern, where the X-chromosomes bearing normal WAS gene were predominantly inactivated, leaving the mutant gene active. Hence, our results suggest that completely inactivating the unaffected paternal X-chromosomes may be the reason for such phenotype in this female patient. SXCI has important implications for genetic counseling of female carriers with a family history of WAS.


Blood ◽  
1988 ◽  
Vol 72 (5) ◽  
pp. 1735-1739
Author(s):  
ER Fearon ◽  
DB Kohn ◽  
JA Winkelstein ◽  
B Vogelstein ◽  
RM Blaese

The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disease characterized by immunodeficiency and severe thrombocytopenia in affected males, but no demonstrable clinical abnormalities in carrier females. Through analysis of the methylation patterns of X-linked genes that display restriction fragment length polymorphisms (RFLPs), we studied the pattern of X-chromosome inactivation in various cell populations from female relatives of patients with WAS. The peripheral blood T cells, granulocytes, and B cells of eight obligate WAS carriers were found to display specific patterns of X-chromosome inactivation clearly different from these of normal controls. Thus, carriers of WAS could be accurately identified using this analysis.


Blood ◽  
1990 ◽  
Vol 75 (12) ◽  
pp. 2369-2374 ◽  
Author(s):  
JM Puck ◽  
KA Siminovitch ◽  
M Poncz ◽  
CR Greenberg ◽  
M Rottem ◽  
...  

Congenital thrombocytopenia may occur in isolation or accompanied by eczema and immunodeficiency, as part of the X-linked hereditary Wiskott- Aldrich syndrome (WAS). Because the clinical and immunologic picture of WAS is variable, particularly early in life, definite diagnosis cannot always be made in cases with a negative family history. Two unrelated males with sporadic congenital thrombocytopenia had only questionable immunologic abnormalities as infants, making them clinically indistinguishable from cases of isolated thrombocytopenia, although one developed episodic neutropenia and the other began to manifest a multisystem autoimmune disease at 2 years of age. Evaluation of X chromosome inactivation in the T cells of both patients' mothers showed each of these women to have the same highly skewed X chromosome inactivation pattern seen in carriers of typical familial WAS. A T-cell defect was subsequently directly demonstrated in the second patient, whose lymphocytes failed to proliferate to periodate and anti-CD43. Taken together, these data suggest the presence of T cell immunodeficiency consistent with WAS in these patients. Furthermore, their mothers were found to have a very high likelihood of being carriers, lending support to the diagnosis of a hereditary disease in these boys and making possible genetic prediction in other family members and subsequent pregnancies.


1987 ◽  
Vol 21 (4) ◽  
pp. 313A-313A ◽  
Author(s):  
Donald B Kohn ◽  
Eric R Fearon ◽  
Jerry A Winklestein ◽  
Bert Vogelstein ◽  
R Michael Blaese

2003 ◽  
Vol 31 (3) ◽  
pp. 332-337 ◽  
Author(s):  
Nuria Andreu ◽  
Núria Pujol-Moix ◽  
Luis Martinez-Lostao ◽  
Marta Oset ◽  
Eduardo Muñiz-Diaz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document